Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds (CLASS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02693262
Recruitment Status : Recruiting
First Posted : February 26, 2016
Last Update Posted : June 7, 2019
Sponsor:
Collaborator:
Biotronik, Inc.
Information provided by (Responsible Party):
Jonathan Hsu, University of California, San Diego

Brief Summary:
Dr. Jonathan Hsu and Dr. Eric Adler are conducting a research study to find out more about how implantable cardiac defibrillator (ICD) settings can be adjusted to improve patient cardiovascular health and quality of life. Patients are being asked to participate in this study if they have a history of heart failure and have or are scheduled to be implanted with a BIOTRONIK ICD that is capable of closed loop stimulation (CLS). CLS is a device setting that works with the cardiovascular system to optimize their heart rate during physical activity. This study is comparing BIOTRONIK's CLS setting to a standard accelerometer setting, which also is able to adjust the heart rate by movement sensors, when necessary. This study has been initiated by Dr. Hsu and Dr. Adler and is financially supported by BIOTRONIK, Inc. There will be approximately 15 participants in this trial.

Condition or disease Intervention/treatment Phase
Heart Failure ICD Chronotropic Incompetence Device: CLS Mode on Biotronik CRT-D Device: Accelerometer Mode on Biotronik CRT-D Not Applicable

Detailed Description:

This study is a prospective, randomized, single-blind crossover study intended to enroll patients who are implanted or are scheduled to be implanted with a Biotronik CLS and accelerometer capable CRT-D device. Patients will serve as their own control group with regard to modes of rate-adaptive pacing. Patients with a previously implanted Biotronik CRT-D device with CLS-capability will be recruited from health care institutions in San Diego and all dedicated functional testing will be performed at the University of California, San Diego (UCSD). The goal enrollment target for analysis will be 15 patients, with up to 20 patients enrolled to allow for withdrawals.

The purpose of this study is to evaluate whether changes to an implanted ICD can improve the functional status of patients with suspected chronotropic incompetence (CI). CI is a condition in which the heart rate is unable to adequately respond to meet the patient's physical demands, such as walking, climbing stairs, or doing household chores. CI is common in patients with cardiovascular disease, particularly in patients with heart failure. Common clinical management of patients with suspected CI is to activate an accelerometer setting in the cardiac resynchronization therapy with defibrillator (CRT-D) device. An accelerometer will adjust the heart rate to fit the physiological circumstances and needs of the patient based on patient movement only. BIOTRONIK is a company that has developed a novel technology included in the settings for CRT-D devices that offers CLS as an alternative to a standard accelerometer. CLS utilizes sensed electrical properties of the heart in order to assess what may be the best heart rate for both physical and mental demands. This study is designed to compare whether patients will benefit from CLS when compared with standard accelerometer technology.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Rate Response With CLS Versus Accelerometer and Effect on Both Subjective Symptoms and Objective Outcomes in a Heart Failure Population Implanted With Cardiac Resynchronization With Defibrillator Device: The CLASS Trial
Study Start Date : July 2016
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : August 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
Experimental: CLS Mode on Biotronik CRT-D
All 15 patients will be randomized to this group. Their device will be set in the CLS mode for 1 week.
Device: CLS Mode on Biotronik CRT-D
Setting changed and monitored. Quality of life evaluated through CPET, 6 Minute Walk Test, and Rand 36 Questionnaire.

Active Comparator: Accelerometer Mode on Biotronik CRT-D
All 15 patients will be randomized to this group. Their device will be set in the accelerometer rate responsive mode for 1 week.
Device: Accelerometer Mode on Biotronik CRT-D
Setting changed and monitored. Quality of life evaluated through CPET, 6 Minute Walk Test, and Rand 36 Questionnaire.




Primary Outcome Measures :
  1. Cardiovascular health benefits from CLS versus accelerometer based rate responsive pacing [ Time Frame: three months ]
    To evaluate whether patients with left ventricular systolic heart failure implanted with CRT-D therapy who have evidence of chronotropic incompetence will benefit from CLS vs. accelerometer based rate responsive pacing. Objective measurements will be collected and analyzed from CPET and 6 Minute Walk Tests completed.

  2. Quality of life benefits from CLS versus accelerometer based rate responsive pacing [ Time Frame: three months ]
    To evaluate whether patients with left ventricular systolic heart failure implanted with CRT-D therapy who have evidence of chronotropic incompetence will benefit from CLS vs. accelerometer based rate responsive pacing in terms of the patient's quality of life (via RAND-36 Health Outcomes Questionnaire)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with a BIOTRONIK CRT-D device (capable of CLS and accelerometer rate responsive pacing)
  • Patients at least 18 years old
  • Patients who have plausible symptoms of CI based on previous monitoring and clinical symptoms

Exclusion Criteria:

  • Pregnant patients
  • Patients who are unwilling/unable to provide informed consent
  • Patients who are unable to complete study related procedures
  • Current persistent atrial fibrillation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02693262


Contacts
Layout table for location contacts
Contact: Jessica Hunter, BHS 858-246-2402 j2hunter@ucsd.edu
Contact: Maylene Alegre 858-246-2402 malegre@ucsd.edu

Locations
Layout table for location information
United States, California
Sulpizio Cardiovascular Center Recruiting
La Jolla, California, United States, 92037
Contact: Jessica Hunter, BHS    858-246-2402    j2hunter@ucsd.edu   
Contact: Maylene Alegre    858-246-2406    malegre@ucsd.ed   
Principal Investigator: Jonathan Hsu, MD         
Sub-Investigator: Eric Adler, MD         
Sponsors and Collaborators
University of California, San Diego
Biotronik, Inc.
Investigators
Layout table for investigator information
Principal Investigator: Jonathan Hsu, MD University of California, San Diego

Publications:
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008 May 27;117(21):e350-408. doi: 10.1161/CIRCUALTIONAHA.108.189742. Epub 2008 May 15. Erratum in: Circulation.2009 Aug 4; 120(5):e34-5.

Layout table for additonal information
Responsible Party: Jonathan Hsu, Assistant Professor of Medicine, University of California, San Diego
ClinicalTrials.gov Identifier: NCT02693262     History of Changes
Other Study ID Numbers: 151774
First Posted: February 26, 2016    Key Record Dates
Last Update Posted: June 7, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Jonathan Hsu, University of California, San Diego:
defibrillator
heart failure
ICD
CRT-D
cardiac resynchronization therapy
rate response
CLS
closed-loop stimulation
accelerometer
chronotropic incompetence
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases